CellWell record HH-4933
A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease.
Chauvin SD; Price S; Zou J; Hunsberger S; Brofferio A; Matthews H; Similuk M; Rosenzweig SD; Su HC; Cohen JI; Lenardo MJ; Ravell JC
Journal of clinical immunology ยท 2022
In plain language
A randomized controlled trial found that observational studies in 2 patients suggested oral magnesium supplementation could decrease EBV viremia.
- Evidence
- Contested
- Design
- Randomized controlled trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-4933
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.